Remote monitoring of subcutaneous implantable cardioverter defibrillators

BackgroundRemote monitoring (RM) of implantable cardioverter defibrillators (ICD) has been shown to improve patient safety and reduce in-office visits. The subcutaneous ICD (S-ICD) is an effective alternative to transvenous ICD and has recently been endowed with the RM function. However, the RM communicator for S-ICD requires patient interaction to activate data transmission. We assessed patient compliance and acceptance.MethodsPatients with S-ICD received the communicator and were followed up for 15months. Weekly remote transmissions were programmed. Compliance with checks was measured as the number of checks performed by the patient divided by the number of automatic notifications by the communicator. A questionnaire on acceptance of the system was administered to patients.ResultsA total of 106 patients were analyzed. The proportion of weekly checks properly executed by the patients was 94% during the first 3months and 93% from months 12 to 15. Of the checks performed, 93% were on the same day as the automatic notification. On a patient basis, compliance with weekly checks was >85% (less than one check missed per month) in 88% of patients during the first 3months and in 82% from months 12 to 15 (p=0.615). No variables emerged as predictors of lower (85%) long-term compliance with weekly checks. During follow-up, 49 alerts were transmitted and the mean delay between the detected event and the patient transmission was 22days. The majority of patients found the system easy to use and felt confident about being remotely monitored.Conclusions<The level of patient compliance with remote checks is high with current technology for RM of S-ICD. The vast majority of data transmissions are consistently performed on a weekly basis on the day scheduled.